Discover 492 paid clinical trials in Nevada. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Nevada offers a wide array of research opportunities for both healthy participants looking to take part in paid studies, as well as for those with specific medical needs. Major research hubs in Las Vegas, Reno, and Henderson are recruiting volunteers, giving access to cutting-edge treatments and advanced healthcare.
Filter
1
Filter results
Results: 492
FeaturedActive & Responsive
A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
for
Overweight, Prediabetic State, Prehypertension,
Location: Boston MA, New Haven CT, Waterbury CT, Hartsdale NY,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT07794579
Phase 3, Recruiting
Active & Responsive
A Phase 3 Randomized Clinical Trial to Investigate the Safety and Efficacy of Palopegteriparatide at Doses Greater Than 30 μg/Day in Adult Participants With Hypoparathyroidism
for
Hypoparathyroidism, Endocrine System Diseases,
Location: New York NY, New Brunswick NJ, Greenville NC,
Sponsor: Ascendis Pharma Bone Diseases A/S
Sex: All
Age: 18+
Code: NCT07081997
Phase 3, Recruiting
Active & Responsive
An Optimised GA Interventional Trial (Opti-GAIN) to Test if Treatment With CTx001 is Safe and Works for People With Geographic Atrophy (GA)
for
Geographic Atrophy Secondary to Age-related Macular Degeneration,
Location: Carmel IN, La Crosse WI, Dallas TX, Reno NV
Sponsor: Complement Therapeutics
Sex: All
Age: 55+
Code: NCT07392255
Phase 1, Phase 2, Recruiting
Active & Responsive
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
Location: Brewer ME, Scarborough ME, Peabody MA, Boston MA,
Sponsor: National Cancer Institute (NCI)
Sex: Female
Age: 18+
Code: NCT07198074
Phase 3, Recruiting
Active & Responsive
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
for
Intestinal Neoplasms, Gastrointestinal Neoplasms,
Location: Topsham ME, Westbrook ME, Boston MA, Newton MA,
Sponsor: Pfizer
Sex: All
Age: 18+
Code: NCT07222800
Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
Statewide Optimization of Lung Cancer Screening Utilizing the QUILS™ System in Nevada and Mississippi: State-Based Initiative Component
for
Lung Cancer Screening
Location: Tupelo MS, New Albany MS, Gulfport MS, Hattiesburg MS,
Sponsor: Timothy Mullett
Sex: All
Age: 18 - 70+
Code: NCT07682597
Recruiting
Active & Responsive
Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
for
Pancreatic Cancer, Pancreatic Cancer Metastatic, PDAC,
Location: New York NY, Belleville NJ, East Brunswick NJ,
Sponsor: Immuneering Corporation
Sex: All
Age: 18+
Code: NCT07562152
Phase 3, Recruiting
Active & Responsive
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
Study of GS-0415 and How It Works in People With HIV
for
HIV -1 Infection
Location: Boston MA, The Bronx NY, Washington D.C. DC, Durham NC,
Sponsor: Gilead Sciences
Sex: All
Age: 18 - 65
Code: NCT07719491
Phase 1, Recruiting
Active & Responsive
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
for
NASH - Nonalcoholic Steatohepatitis,
Location: South Dartmouth MA, New Haven CT, Manhasset NY,
Sponsor: Akero Therapeutics, Inc
Sex: All
Age: 18 - 70+
Code: NCT06528314
Phase 3, Recruiting
Active & Responsive
A Study to Evaluate the Effect of KarXT on Urological Safety
for
Schizophrenia
Location: Marlton NJ, Philadelphia PA, Boynton Beach FL,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18 - 65
Code: NCT07221877
Phase 4, Recruiting
Active & Responsive
A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis
for
NASH With Fibrosis, MASH With Fibrosis
Location: New Bedford MA, New Haven CT, Manhasset NY, New York NY,
Sponsor: Akero Therapeutics, Inc
Sex: All
Age: 18 - 70+
Code: NCT06215716
Phase 3, Recruiting
Active & Responsive
A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
for
Diabetes Mellitus, Type 2, PreDiabetes, Metabolic Syndrome
Location: Boston MA, Lake Success NY, Mount Kisco NY,
Sponsor: Cleerly, Inc.
Sex: All
Age: 55+
Code: NCT06112418
Recruiting
Active & Responsive
Exercise Neuroprotection in Parkinson's Disease
for
Parkinson Disease
Location: Las Vegas NV
Sponsor: University of Nevada, Las Vegas
Sex: All
Age: 30 - 70+
Code: NCT05854524
Recruiting
Active & Responsive
Evaluation of Efficacy and Safety of Suzetrigine (SUZ) for Pain Associated With Diabetic Peripheral Neuropathy
for
Diabetic Peripheral Neuropathic Pain
Location: Boston MA, East Greenwich RI, Waterbury CT, Brooklyn NY,
Sponsor: Vertex Pharmaceuticals Incorporated
Sex: All
Age: 18 - 70+
Code: NCT07231419
Phase 3, Recruiting
Active & Responsive
Ostomy Primary Closure With 0.1% Betaine/Polyhexanide Wound Irrigation Compared to Pursestring Closure
for
Surgical Site Infection, Wound Surgical, Colorectal Disorders
Location: Las Vegas NV
Sponsor: University of Nevada, Las Vegas
Sex: All
Age: 18+
Code: NCT06309368
Recruiting
Active & Responsive
A Non-Interventional Study Observing Short-Term Progression in Geographic Atrophy (GA)
for
Geographic Atrophy Secondary to Age-related Macular Degeneration,
Location: Bethlehem PA, Wake Forest NC, Durham NC, Oak Forest IL,
Sponsor: Complement Therapeutics
Sex: All
Age: 55+
Code: NCT07144137
Recruiting
Active & Responsive
10,000 Step Club: Community Walking Program for People with Parkinson's Disease
for
Parkinson Disease
Location: Las Vegas NV
Sponsor: University of Nevada, Las Vegas
Sex: All
Age: 30 - 70+
Code: NCT06605183
Recruiting
Active & Responsive
A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)
for
Triple Negative Breast Neoplasms
Location: Quebec, Chicoutimi, Mineola NY, New York NY,